{
  "KK9473L_syn_1": "Protocol: Study #2024-BR-0847.\nPt: [REDACTED].\nIndication: Staging.\nEBUS: 4R, 7, 10R.\nResults: 4R/7 Malignant (N2). 10R Benign.\nMetrics: Systematic exam complete. Photos taken.",
  "KK9473L_syn_2": "PROCEDURE NOTE: [REDACTED] in the Bronchoscopy Registry Study. EBUS-TBNA was performed for staging of RLL adenocarcinoma. Stations 4R, 7, and 10R were id[REDACTED] and sampled systematically. ROSE confirmed malignancy in 4R and 7 (N2 disease). Station 10R was negative. All quality metrics including photodocumentation and molecular sampling were met.",
  "KK9473L_syn_3": "Coding: 31653 (EBUS-TBNA 3 stations).\nSites: 4R, 7, 10R.\nDiagnosis: RLL Adenocarcinoma staging.\nNote: N2 disease confirmed. Study protocol followed.",
  "KK9473L_syn_4": "Resident Note\nPatient: [REDACTED]\nProcedure: EBUS Staging\n- Mod sedation.\n- EBUS TBNA: 4R, 7, 10R.\n- 4R/7 positive for cancer.\n- 10R negative.\n- No complications.\n- Systematic exam done.",
  "KK9473L_syn_5": "protocol bronch registry study subject s-047 [REDACTED] 68 male. indication staging rll cancer. sedation versed fentanyl. ebus stations sampled 4r 10mm 4 passes rose positive. station 7 15mm 4 passes rose positive. station 10r 7mm 3 passes negative. quality metrics met systematic exam photos taken. n2 disease confirmed no adverse events.",
  "KK9473L_syn_6": "PROTOCOL: Bronchoscopy Registry Study #2024-BR-0847 SUBJECT ID: [REDACTED] DEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018) DATE: [REDACTED] OPERATOR: De-id[REDACTED] per protocol PRIMARY INDICATION: Mediastinal lymph node staging TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven) ANESTHESIA PROTOCOL: ... [Rest of text]",
  "KK9473L_syn_7": "[Indication]\nStaging RLL Adenocarcinoma.\n[Anesthesia]\nModerate Sedation.\n[Description]\nSystematic EBUS. Sampled 4R, 7, 10R. 4R and 7 positive for malignancy. 10R negative.\n[Plan]\nFollow protocol/Tumor board.",
  "KK9473L_syn_8": "[REDACTED] our bronchoscopy study today. We needed to stage his right lower lobe cancer. Using EBUS, we sampled lymph nodes at stations 4R, 7, and 10R. The samples from 4R and 7 came back positive for cancer cells, confirming spread to the mediastinum. We made sure to take photos and follow all the study protocols strictly.",
  "KK9473L_syn_9": "PROTOCOL: Bronchoscopy Registry Study #2024-BR-0847. PRIMARY INDICATION: Mediastinal lymph node staging. EBUS-TBNA STATIONS SAMPLED: Station 4R: 10mm, 4 passes, ROSE Positive. Station 7: 15mm, 4 passes, ROSE Positive. Station 10R: 7mm, 3 passes, ROSE Adequate. QUALITY METRICS: Systematic evaluation executed. Photodocumentation complete. DIAGNOSTIC YIELD: N2 disease verified.",
  "KK9473L": "PROTOCOL: Bronchoscopy Registry Study #2024-BR-0847\nSUBJECT ID: [REDACTED]\nDEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)\nDATE: [REDACTED]\nOPERATOR: De-id[REDACTED] per protocol\n\nPRIMARY INDICATION: Mediastinal lymph node staging\nTARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)\n\nANESTHESIA PROTOCOL:\n└─ Agent: Midazolam IV\n   ├─ Dose: 2mg initial, 1mg supplemental at T+15min\n   └─ Total: 3mg\n└─ Agent: Fentanyl IV\n   ├─ Dose: 50mcg initial, 25mcg supplemental at T+20min\n   └─ Total: 75mcg\n└─ Sedation Level: Ramsay Scale maximum 3\n└─ Monitoring Frequency: BP q5min, continuous SpO2\n\nEBUS-TBNA STATIONS SAMPLED:\n├─ Station 4R\n│  ├─ Size: 10mm short-axis\n│  ├─ Passes: 4\n│  ├─ ROSE: Positive for malignant cells\n│  └─ PET: Positive (SUV 6.2)\n├─ Station 7\n│  ├─ Size: 15mm short-axis\n│  ├─ Passes: 4\n│  ├─ ROSE: Positive for malignant cells\n│  └─ PET: Positive (SUV 8.1)\n└─ Station 10R\n   ├─ Size: 7mm short-axis\n   ├─ Passes: 3\n   ├─ ROSE: Adequate, benign lymphocytes\n   └─ PET: Negative\n\nQUALITY METRICS:\n├─ Systematic evaluation (N3→N2→N1): YES\n├─ Photodocumentation all accessible stations: YES\n├─ ROSE adequacy all sampled nodes: YES\n├─ Molecular testing samples obtained: YES (from station 7)\n└─ Protocol adherence: 100%\n\nADVERSE EVENTS:\n└─ None (Grade 0)\n\nDIAGNOSTIC YIELD: Pending final pathology (preliminary: N2 disease confirmed)\n\nPATIENT [REDACTED] (SYNTHETIC):\nName: [REDACTED] | MRN: [REDACTED] | DOB: [REDACTED]"
}
